Abstract
[125I] or [123I] labeled (±)-exo-2-(2-iodo-5-pyridyl)-7-azabicyclo[2.2.1]heptane (IPH), an analog of the high-affinity nicotinic acetylcholine receptor ligand, epibatidine, was prepared by a nucleophilic non-isotopic exchange reaction. Treatment of the 2-bromo pyridyl precursor with radioiodide and in situ generated Cu(I) at high temperature (200-220°C) gave [125I] or [123I]IPH that was purified by reverse phase HPLC. Radiochemical yields ranged from 31-50% for the [125I] labeling (average = 37%, n = 7) and 20% for [123I]. Both [125I]IPH and [123I]IPH were of high radiochemical purity (> 96%) and high specific activity (average of 1540 mCi/μmol (57 GBq/μmol) for [125I]IPH and >1750 mCi/μmol (65 GBq/μmol) for [123I]IPH).
Original language | English (US) |
---|---|
Pages (from-to) | 39-48 |
Number of pages | 10 |
Journal | Journal of Labelled Compounds and Radiopharmaceuticals |
Volume | 39 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1997 |
Keywords
- Brain imaging
- Copper-assisted halogen-exchange
- Epibatidine
- I
- I
- Nicotinic receptors
- Single photon emission computed tomography
ASJC Scopus subject areas
- Analytical Chemistry
- Biochemistry
- Radiology Nuclear Medicine and imaging
- Drug Discovery
- Spectroscopy
- Organic Chemistry